These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19458885)

  • 1. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians.
    Dong SS; Liu XG; Chen Y; Guo Y; Wang L; Zhao J; Xiong DH; Xu XH; Recker RR; Deng HW
    Calcif Tissue Int; 2009 Aug; 85(2):104-12. PubMed ID: 19458885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M; Lin L; Cui H
    Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL/RANK/OPG Polymorphisms and Heel Quantitative Ultrasound in Young Adults.
    Correa-Rodríguez M; Schmidt-RioValle J; Rueda-Medina B
    Nurs Res; 2017; 66(2):145-151. PubMed ID: 28252575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
    Tu P; Duan P; Zhang RS; Xu DB; Wang Y; Wu HP; Liu YH; Si L
    Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
    Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
    Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
    Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
    J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis.
    Eun IS; Park WW; Suh KT; Kim JI; Lee JS
    Eur Spine J; 2009 Dec; 18(12):1936-40. PubMed ID: 19705167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
    Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
    J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.
    Roshandel D; Holliday KL; Pye SR; Ward KA; Boonen S; Vanderschueren D; Borghs H; Huhtaniemi IT; Adams JE; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; ONeill TW;
    Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
    Knevel R; de Rooy DP; Saxne T; Lindqvist E; Leijsma MK; Daha NA; Koeleman BP; Tsonaka R; Houwing-Duistermaat JJ; Schonkeren JJ; Toes RE; Huizinga TW; Brouwer E; Wilson AG; van der Helm-van Mil AH
    Arthritis Res Ther; 2014 May; 16(3):R108. PubMed ID: 24886600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
    Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
    BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Genetic Variants of
    Wang CM; Tsai SC; Lin JC; Wu YJ; Wu J; Chen JY
    Mediators Inflamm; 2019; 2019():8029863. PubMed ID: 31015798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
    Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
    J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.
    Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P
    Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Remodeling and Bone Structural Genes in Legg-Calvé-Perthes Disease: The
    Cruz-Ortíz BL; Hernández-Zamora E; Reyes-Maldonado E; Rodríguez-Olivas AO; Rubio-Lightbourn J; Martínez-Ramírez CO; Castro-Hernández C; Lezama-Palacios R; Casas-Avila L
    DNA Cell Biol; 2024 Jun; 43(6):288-297. PubMed ID: 38648538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the OPG gene associated with breast cancer.
    Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G
    BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
    Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.